Cognition Therapeutics, Inc.
CGTX
$2.86
-$0.325-10.22%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.73M | -8.48M | -7.84M | -9.94M | -7.04M |
| Total Depreciation and Amortization | 61.00K | 45.00K | 71.00K | 70.00K | 67.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 621.00K | 586.00K | 534.00K | 896.00K | 1.15M |
| Change in Net Operating Assets | 429.00K | -2.03M | -1.15M | 2.12M | -170.00K |
| Cash from Operations | -5.62M | -9.88M | -8.38M | -6.85M | -6.00M |
| Capital Expenditure | -- | -- | -1.00K | 0.00 | -3.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -1.00K | 0.00 | -3.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -120.00K | -118.00K | -195.00K | -185.00K | -181.00K |
| Issuance of Common Stock | 877.00K | 1.46M | 12.91M | 514.00K | 1.39M |
| Repurchase of Common Stock | -5.00K | -46.00K | 0.00 | 0.00 | -22.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -1.33M | -- | -1.33M |
| Cash from Financing | 752.00K | 1.30M | 11.38M | 329.00K | -138.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.87M | -8.58M | 3.00M | -6.52M | -6.14M |